Oxford Immunotec (OXFD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | -15,385 | 26,109 | 19,154 | 17,110 | 16,785 |
| Cost of Goods | -11,783 | 11,503 | 8,606 | 8,165 | 8,318 |
| Gross Profit | -3,602 | 14,606 | 10,548 | 8,945 | 8,467 |
| Operating Expenses | 2,046 | 19,355 | 18,489 | 16,304 | 15,003 |
| Operating Income | -6,431 | -4,246 | -7,335 | -7,194 | -6,218 |
| Interest Expense | 793 | 54 | 0 | 17 | 0 |
| Other Income | -729 | 364 | 886 | 197 | -120 |
| Pre-tax Income | -7,953 | -3,936 | -6,449 | -7,014 | -6,338 |
| Income Tax | -3,866 | 60 | -3 | 35 | 52 |
| Net Income Continuous | -4,087 | -3,996 | -6,446 | -7,049 | -6,390 |
| Net Income | $-4,858 | $-3,996 | $-6,446 | $-7,049 | $-6,390 |
| EPS Basic Total Ops | -0.21 | -0.18 | -0.29 | -0.32 | -0.28 |
| EPS Basic Continuous Ops | -0.19 | -0.18 | -0.29 | -0.32 | -0.28 |
| EPS Diluted Total Ops | -0.21 | -0.18 | -0.29 | -0.32 | -0.28 |
| EPS Diluted Continuous Ops | -0.19 | -0.18 | -0.29 | -0.32 | -0.28 |
| EBITDA(a) | $-7,566 | $-3,384 | $-6,711 | $-6,613 | $-5,609 |